142 related articles for article (PubMed ID: 36254639)
1. Anti-cancer effects of selective cannabinoid agonists in pancreatic and breast cancer cells.
Turgut NH; Armagan G; Kasapligil G; Erdogan MA
Bratisl Lek Listy; 2022; 123(11):813-821. PubMed ID: 36254639
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
6. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
8. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells.
Farsandaj N; Ghahremani MH; Ostad SN
J Environ Pathol Toxicol Oncol; 2012; 31(4):377-87. PubMed ID: 23394450
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis.
Bilgic E; Guzel E; Kose S; Aydin MC; Karaismailoglu E; Akar I; Usubutun A; Korkusuz P
Acta Histochem; 2017 Jun; 119(5):523-532. PubMed ID: 28549792
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation.
Crunfli F; Vrechi TA; Costa AP; Torrão AS
Neurotox Res; 2019 Apr; 35(3):516-529. PubMed ID: 30607903
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
Alenabi A; Malekinejad H
Mol Cell Biochem; 2021 Sep; 476(9):3285-3301. PubMed ID: 33886060
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
FEBS Lett; 2005 Dec; 579(30):6885-9. PubMed ID: 16337199
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
Bettiga A; Aureli M; Colciago G; Murdica V; Moschini M; Lucianò R; Canals D; Hannun Y; Hedlund P; Lavorgna G; Colombo R; Bassi R; Samarani M; Montorsi F; Salonia A; Benigni F
Sci Rep; 2017 Feb; 7():42157. PubMed ID: 28191815
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of cannabinoid receptor agonists and a cyclooxygenase-2 inhibitor in rat bone tumor pain.
Cui JH; Ju J; Yoon MH
Pharmacology; 2013; 92(3-4):150-7. PubMed ID: 24008428
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
20. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Silva GB; Atchison DK; Juncos LI; García NH
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]